Quantitative proteomics Microarray technology is finding its way into quantitative proteomics through the construction of what are most accurately called 'protein-detecting microarrays' 1.

Microarrays permit the analysis of gene expression, DNA sequence variation, protein levels, tissues, cells and other biological and chemical molecules in a massively parallel format. Robust ...

The microarray is a very recent development in the field of biotechnology. Scientists are now able to understand the gene functions of any organism by tracking down thousands of genes and their ...

Carbohydrate microarrays have become essential screening tools for revealing the functions of biomolecules that interact with sugars, providing essential information on the mechanisms of diseases ...

The first study of the use of microarray patches to vaccinate children has shown that the method is safe and induces strong immune responses. The phase 1/2 randomized trial compared results from ...

The microarray is a recently developed technology used in cancer research and in the pharmacological treatment of other diseases such as oral lesions. In this technology, a microscope slide ...

Courtesy of CombiMatrix The research community's rapid acceptance of microarrays notwithstanding, technical challenges remain. Biochip developers continue to grapple with these issues while upgrading ...

Trial represents first-ever CDC-sponsored clinical trial of vaccine delivered via “patch” technology and utilizes Micron’s first-in-class dissolvable microarray technologyResearch builds on ...

The first study of the use of microarray patches to vaccinate children has shown that the method is safe and induces strong immune responses. The phase 1/2 randomized trial compared results ...

Vaxxas, a clinical-stage biotechnology company commercializing a novel high-density microarray patch (HD-MAP) vaccination platform, has been named a C ...

Microarrays in a Microtube Image courtesy of CLONDIAG Companies in the microarray sector are trying to take the technology out of core facilities and put it into the hands of individual researchers by ...

The acquisition of the Arizona-based microarray solutions company extends SCHOTT’s manufacturing presence in the United States and strengthens its bioscience capabilities. Customers will benefit ...